XOMA
NASDAQ · Biotechnology
Xoma Royalty Corporation
$41.62
+0.33 (+0.80%)
Open$41.31
Previous Close$41.29
Day High$41.69
Day Low$41.20
52W High$42.81
52W Low$22.29
Volume—
Avg Volume691.7K
Market Cap444.29M
P/E Ratio14.01
EPS$1.76
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
-3.8% upside
Current
$41.62
$41.62
Target
$40.02
$40.02
$30.13
$40.02 avg
$66.99
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.96M | 33.35M | 45.56M |
| Net Income | 18.83M | -14,563,878 | -2,452,418 |
| Profit Margin | 60.8% | -46.1% | -5.4% |
| EBITDA | 24.09M | -22,420,452 | -2,902,540 |
| Free Cash Flow | — | — | -1,967,070 |
| Rev Growth | +105.3% | -9.3% | +14.7% |
| Debt/Equity | 1.05 | 1.44 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |